Heel medicines are available in 50 countries worldwide. Choose your country below to learn more.
Heel’s Benefit Programs are among the Best of German CompaniesHeel has one of the best and most innovative benefit programs for employees in Germany. This is the result of a study that has been conducted for the first time by the business magazine "Capital" and the recruitment and management consultancy Kienbaum. In the ranking “Best Benefits of the Germany Economy” Heel reaches the sixth position of all German companies that participated in the study. More on "Best Benefits of the German Economy"
Hans-Heinrich Reckeweg Clinical Case Award 2017 - Submission closedBiologische Heilmittel Heel GmbH supports the acknowledgement of clinical case reporting in the form of the annual Hans-Heinrich Reckeweg Clinical Case Award. The Award is bestowed on the premises of the International Award Committee for excellent reporting in accordance with the CARE guidelines (care-statement.org), ensuring transparency and accuracy of health research reporting. The submission is now closed. More on the Hans-Heinrich Reckeweg Clinical Case Award
Press releaseHeel’s Traumeel® and Zeel® T shown to reduce pain of OA of the knee by more than 60% in MOZArT trial - Clinical data released at the 2015 European League Against Rheumatism (EULAR) congress show Traumeel® and Zeel® T co-administered intra-articular (IA) injections provide a new first line injection treatment option in the management of moderate to severe osteoarthritis of the knee, where oral pain management failed. More press releases